Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant
Clinical trial NCT02657161 · COMPLETED
Trial details
- NCT number
- NCT02657161
- Sponsor
- Yisheng Biopharma (Singapore) Pte. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-07-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.